Interstitial lung disease with autoantibodies againstaminoacyl-tRNA synthetases in the absence of clinically apparent myositis*

https://doi.org/10.1016/S0049-0172(96)80026-6Get rights and content

Abstract

Autoantibodies against aminoacyl-tRNA synthetases (antisynthetases) havebeen found to be highly specific for polymyositis and dermatomyositis and to correlate strongly with complicating interstitial lung disease (ILD). We describe the clinical presentations and course of 10 patients with ILD and anti-synthetase antibodies in whom underlying myositis was not clinically evident. Anti-PL-12 antibodies (antialanyl-tRNA synthetase) were most common (60%), followed by anti-Jo-1 (antihistidyl-tRNA synthetase) and anti-OJ (anti-isoleucyl-tRNA synthetase) (20% each). All 10 patients had anticytoplasmic antibodies by indirect immunofluorescence on HEp-2 cells. Five of 10 presented with features of connective tissue disease, whereas two presented with acute respiratory failure, two with insidious onset of diminished exercise tolerance, and one with persistent cough. All but one patient received corticosteroids, four were given oral cyclophosphamide, and two azathioprine. ILD resolved or stabilized in five patients (50%), and progressed in four (40%). The “antisynthetase syndrome” may occur in the absence of clinical myositis, and the ILD in these patients is usually responsive to therapy. Antisynthetase testing should be considered in patients with ILD who have a cytoplasmic pattern by antinuclear antibody (ANA) testing on HEp-2 cells, because early recognition and treatment of such patients affects their clinical course.

References (33)

  • TargoffI.N. et al.

    Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity

    J Immunol

    (1987)
  • MathewsM.B. et al.

    Antithreonyl tRNA synthetase: A second myositis-related autoantibody

    J Exp Med

    (1984)
  • BunnC.C. et al.

    Autoantibodies against alanyl-tRNA symhetase and tRNA (ALA) coexist and are associated with myositis

    J Exp Med

    (1986)
  • TargoffI.N.

    Autoantibodies to aminoacyl-transfer RNA synthesases for isoleucine and glycine: Two additional synthetases are antigenic in myositis

    J Immunol

    (1990)
  • YoshidaS. et al.

    The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases: A marker for a subset of polymyositiswith interstitial pulmonary fibrosis

    Arthritis Rheum

    (1983)
  • BernsteinR.M. et al.

    AntiJo-1 antibody: A marker for myositis with interstitial lung disease

    Br Med J

    (1984)
  • Cited by (0)

    *

    Supported by a grant from the Muscular Dystrophy Association,and the George S. Bruce, Jr., Professorship in Arthritis and Other Rheumatic Diseases (Dr. Arnett); and NIH grants no. AR32214 and no. AI27181 and Department of Veterans Affairs Medical Research Funds (Dr. Targoff).

    View full text